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Our research focuses on the molecular design and synthesis of specific inhibitors of physiologically important enzymes 
(biocatalysts). The enzyme inhibitors are used for probing the reaction mechanisms, three-dimensional structures and 
identifying the physiological roles of the enzymes. The finely designed inhibitors are further elaborated to develop useful 
bioactive substances that could knockout the specific enzyme in vivo to develop lead compounds for novel pharmaceuticals, 
agrochemicals and cosmetic ingredients. Our current research includes the design, synthesis and applications of transition-
state analogue and/or mechanism-based inhibitors of such enzymes as γ-glutamyl transpeptidase, a key enzyme in glutathione 
metabolism, asparagine synthetase, an important enzyme for cancer chemotherapy, and 4-coumaroyl CoA ligase that plays 
a pivotal role in the biosynthesis of a vast array of phenylpropanoid in plants. The identification of the genes of hitherto 
unknown enzymes for biosynthesis of phenylpropanoid volatiles 
in plants are also pursued to shed light on the detailed reaction 
mechanisms and the physiological function of the biosynthetic 
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Development and Applications of Specific 
Inhibitors of γ-Glutamyl Transpeptidase, a 
Key Enzyme in Glutathione Metabolism
Glutathione (GSH, γ-Glu-Cys-Gly) is a ubiquitous redox 
active tripeptide containing Cys and plays central roles in 
detoxification of reactive oxygen species (ROS) and toxic 
xenobiotics in the front line of cellular defense system. 
γ-Glutamyltranspeptidase (GGT) is a key enzyme in GSH 
metabolism that catalyzes the cleavage of γ-glutamyl 
peptide bond of extracellular GSH to supply cells with Cys, 
a rate-limiting substrate for intracellular GSH biosynthesis. 
Hence GGT is implicated in many physiological disorders 
such as drug resistance of cancer cells, cardiovascular 
diseases and asthma. We have developed a phosphonate-
based mechanism-based inhibitor, GGsTopTM, that was a 
highly specific and non-toxic inhibitor of GGT. A series 
of phosphonate-based GGT inhibitors with a peptidyl side 
chain have also been synthesized for evaluation as inhibitors 
of human and E. coli GGTs to probe the Cys-Gly binding 
site (Figure 1).
Figure 1. Mechanism-based inhibition of GGT by GGsTopTM and peptidyl 
phosphonate inhibitors 1a-g.
Interestingly, GGsTopTM, a highly efficient inhibitor of 
human GGT, induces cellular anti-oxidative stress response. 
As a result, this compound exhibited interesting biological 
activities such as increasing the biosynthesis of type I 
collagen, elastin and HSP47 of human dermal fibroblasts 
(Figure 2). These properties, along with its non-toxic nature, 
allowed GGsTopTM to serve as a novel active ingredient for 
anti-ageing cosmetics. This compound are now marketed 
under a trade name of “Nahlsgen®” and has attracted signifi-
cant interests from the cosmetic market.
Figure 2. Mechanism for activation of human fibroblasts by GGT inhibitor, 
GGsTopTM.
Biological Activities of Plant Second 
Metabolite Phenylpropenes and Their Mode 
of Action
Phenylpropenes having a C6-C3 unit carbon skeleton with 
a variety of substituents on the benzene ring (C6) and the 
propene side chain (C3) are one of the most prevalent plant 
secondary metabolites that exhibit various biological activi-
ties such as bacteriocidal, anti-fungal, anti-viral, anti-
oxidative and anti-tumor activities. Eugenol and its de-
rivatives such as estragole, O-methyleugenol, safrole 
are typical volatile phenylpropenes found widely across 
the plant kingdom and are considered to be a part of the 
chemical self-defense system of plants. Among them, 
O-dimethylallyleugenol (DMAE) is a unique eugenol 
derivative found in enormous amount in leaves of Japanese 
star anise (lllicium anisatum) and exhibits unique activity 
of suppression of ovipositon of mites, whereas its parent 
compound eugenol does not. We therefore are interested 
in the mode of action of DMAE and performed structure-
activity relationship studies. 
O-alkyled eugenol such as estragole, methyleugenol and 
safrole did not show any ovipositon suppression activity at 
2 mM, whereas O-allyl-based alkenyl derivatives include 
DMAE solely exhibited significant activity. Furthermore, the 
activity was observed only for the allyl benzene with O-allyl 
substituent at the para position. Interestingly, the activities 
of DMAE and O-allyleugenol (AE) were totally abolished 
in the presence of piperonyl butoxide (PBO), a competitive 
inhibitor of cytochrome P450 enzyme, suggesting that the 
metabolic activation of O-allyleugenols involving P450 is 
responsible for the biological activity and the formation of 
p-quinone methide is inferred as an active entity.
